As it turns 20, the Global Fund marks the extraordinary progress that has been made in the fight against HIV, tuberculosis and malaria, recommits to ending these three epidemics by 2030, and reflects on a new pandemic that is threatening to knock us off track: COVID-19.
The history of the Global Fund begins in the late 1990s when AIDS, tuberculosis and malaria were collectively killing more than six million people every year. Born from urgency and designed from the start to be a game-changing and inclusive partnership, the Global Fund unites the world’s commitment, resources, and capabilities to fight the world’s most deadly infectious diseases and contribute to better health for all as set out in the Sustainable Development Goals.
Twenty years later, motivated by optimism, persistence and purpose, the Global Fund has helped cut deaths from HIV by 61%, malaria by 46% and tuberculosis by 25%. Overall, the partnership has saved 38 million lives.
To date, the Global Fund has deployed more than US$45 billion to fight HIV, tuberculosis, and malaria, and strengthen health systems and community health networks. Thanks to the continued support of donors, it continues to deliver impact at scale, providing 73% of international funding for efforts against tuberculosis, 65% against malaria and 21% for HIV.
When COVID-19 hit the world, the Global Fund responded immediately and has already provided more than US$1 billion to help countries fight COVID-19 with critical tests, treatments and medical supplies, protect frontline health workers, adapt lifesaving HIV, TB and malaria programs, and reinforce fragile systems for health.
The Global Fund is now the primary channel for providing grant support to low- and middle-income countries for COVID-19 tests, treatments (including medical oxygen), personal protective equipment (PPE) and critical elements of health system strengthening.